Evidence map›Paper›PMID 31881661›Full record

ArticleNutrients2019

Estrogenic, Antiestrogenic and Antiproliferative Activities of

Paramita Basu, Elizabeth Meza, Michael Bergel, Camelia Maier

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. International journal of molecular sciences · 2026
    Article
  2. Review
  3. Differential Biological Effects ofAntioxidants (Basel, Switzerland) · 2024
    Article
  4. In vitro study of the antioxidant, antiproliferative, and anthelmintic properties of some medicinal plants of Kokrajhar district, India.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2021
    Article
  5. Article
  6. High-ThroughputFrontiers in oncology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Paramita BasuDepartment of Biology, Texas Woman's University, Denton, TX 76204-5799, USA.
Elizabeth MezaDepartment of Biology, Texas Woman's University, Denton, TX 76204-5799, USA.
Michael BergelDepartment of Biology, Texas Woman's University, Denton, TX 76204-5799, USA.
Camelia MaierDepartment of Biology, Texas Woman's University, Denton, TX 76204-5799, USA.ORCID 0000-0001-7389-6678
Texas Woman's University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Estrogen receptor antagonists are effective in breast cancer treatment. However, the side effects of these treatments have led to a rise in searching for alternative therapies. The present study evaluated the estrogenic, antiestrogenic, and antiproliferative activities of

Indexed as

Antineoplastic Agents, PhytogenicBreast NeoplasmsCell Line, TumorCell ProliferationDiterpenesEstradiol CongenersEstrogen AntagonistsEuphorbiaHumansLatexPhytochemicalsPlant ExtractsAntineoplastic Agents, PhytogenicDiterpenesEstradiol CongenersEstrogen AntagonistsLatexPhytochemicalsPlant Extractsresiniferatoxinbreast cancerEuphorbia bicolorlatexMCF-7MDA-MB-231MDA-MB-469resiniferatoxinrutinT47-D

Identifiers

PMID31881661
PMCPMC7019628
OpenAlexW2997004826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.